For this purpose, InSphero AG, a specialist in the field of 3D spheroids and cell-based assays for pharmaceutical drug discovery and safety testing, has received an eight-figure amount in its latest round of financing, according to a recent press release on the matter.
Insphero is a private company founded in 2009 with its headquarters in Schlieren, Switzerland. The company has also a U.S. subsidiary in Brunswick, Maine, USA. The business is focused on manufacturing 3D cell culture models and organ chips that mimic human biology.
More information:
https://www.bionity.com/de/news/1180042/zeiss-ventures-investiert-in-das-life-science-start-up-insphero-um-die-3d-zellkulturforschung-voranzutreiben.html?utm_source=newsletter&utm_medium=email&utm_campaign=bionityde&WT.mc_id=ca0264